Press Release | NeoGenomics Laboratories

October 26, 2016

NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016

October 11, 2016

NeoGenomics Schedules its Q3 2016 Earnings Release for October 26, 2016

July 26, 2016

NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

July 5, 2016

NeoGenomics Schedules its Q2 2016 Earnings Release for July 26, 2016

April 27, 2016

NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains

April 11, 2016

NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016

March 1, 2016

NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains

January 26, 2016

NeoGenomics Schedules its Q4 2015 and Full Year 2015 Earnings Release for March 1, 2016

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients